Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 22.73M
March 31, 2026 22.71M
December 31, 2025 22.62M
September 30, 2025 22.62M
June 30, 2025 22.62M
March 31, 2025 22.58M
December 31, 2024 22.50M
September 30, 2024 22.49M
June 30, 2024 22.49M
March 31, 2024 22.47M
December 31, 2023 22.38M
September 30, 2023 26.99M
June 30, 2023 26.98M
March 31, 2023 26.96M
December 31, 2022 22.24M
September 30, 2022 26.83M
June 30, 2022 26.82M
March 31, 2022 26.81M
December 31, 2021 22.42M
September 30, 2021 26.75M
June 30, 2021 26.75M
March 31, 2021 26.73M
December 31, 2020 22.47M
September 30, 2020 26.62M
June 30, 2020 22.41M
Date Value
March 31, 2020 22.47M
December 31, 2019 22.51M
September 30, 2019 22.51M
June 30, 2019 22.56M
March 31, 2019 22.61M
December 31, 2018 22.51M
September 30, 2018 22.51M
June 30, 2018 22.52M
March 31, 2018 22.65M
December 31, 2017 22.51M
September 30, 2017 22.52M
June 30, 2017 22.54M
March 31, 2017 22.47M
December 31, 2016 22.42M
September 30, 2016 22.40M
June 30, 2016 22.32M
March 31, 2016 22.29M
December 31, 2015 22.28M
September 30, 2015 22.26M
June 30, 2015 22.30M
March 31, 2015 22.28M
December 31, 2014 22.26M
September 30, 2014 22.28M
June 30, 2014 22.31M
March 31, 2014 22.36M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Olin Corp. 114.00M
Ascent Industries Co. 9.010M
Solesence, Inc. 70.65M
BioLargo, Inc. 325.23M
The Chemours Co. 150.46M